Iepatic vitamin D 25‐hydroxylase: Inhibition by bile duct ligation or bile salts
Erry J. G. Bolt, Michael D. Sitrin, Murray J. Favus, Irwin H. Rosenberg – 1 September 1981 – Bone disease and low serum levels of 25‐hydroxyvitamin D are prevalent in cholestatic syndromes such as primary biliary cirrhosis and biliary atresia. Defective hydroxylation, along with malabsorption of vitamin D, could be a factor in 25‐hydroxyvitamin D depletion. To assess hepatic hydroxylation during experimental cholestasis, we studied vitamin D 25‐hydroxylase activity in liver homogenates of rats after 7, 14, and 21 days of bile duct ligation.